 Coronary artery thrombolysis comparison approved agents agents lysis thrombi coronary arteries alteplase anistreplase streptokinase undergone critical clinical experimental trials Europe United Global comparison efficacy alteplase effective percent patency anistreplase percent streptokinase percent Streptokinase anistreplase allergenic repeat administration feasible short-term distinct advantage alteplase accurate dosing thrombolytic agents skillful use aspirin heparin efficacy thrombolytic therapy risk recanalization rate percent thrombolytic agent first hour thrombosis Administration development thrombosis possible agent hospital physicians paramedics